ANALYSIS OF RADIATION REACTIONS OF SKIN AFTER HYPOFRACTIONATED RADIATION THERAPY OF BREAST CANCER

Background: In the Republic of Kazakhstan, breast cancer takes a leading position among all malignant neoplasms in women. Radiation therapy is a standard and obligatory component of complex treatment of breast cancer. Daily fractions use of 2 Gy to a total focal dose of 50 Gy is the traditional standard scheme for radiotherapy treatment. However, due to the increase in the number of detected diseases at an early stage, approaches to the treatment of breast cancer have changed in recent years. Acute radiation skin reactions are one of the most frequent side effects of this type of treatment, which in turn is a risk of stress in most patients, and in some cases, a factor limiting the receipt of the full dose of radiation according to the treatment plan. Determination of the most appropriate tactics to prevent acute skin toxicity remains a problem for oncologists, due to the limited number of clinical studies that would help predict skin reaction for irradiation, as well as measures to prevent radiation-induced skin damage/

The aim of the study is the incidence assessment of skin toxicity after a daily using of 2.7 Gy to a total dose of 43.2 Gy to the patient’s breast.

Materials and methods: Study design is non-randomized clinical trial. In the period from 2014 to 2017 we analyzed the results of treatment of two groups of patients who received hypofractionated radiation therapy (n = 80), as well as radiotherapy in the traditional mode (n = 80). The skin toxicity was examined at the course of the treatment, 3 and 6 months after treatment by the international scale for assessing criteria of acute radiation reactions developed by the American Radiation Therapy Oncology Group (RTOG, 1995). Mann-Whitney U test was used for comparing data between two groups. Analysis was performed with SPSS ver.20 software.

Results: It was established that after providing hypofractionated radiation therapy more than 80% of the patients had no acute radiation reactions of skin; the average toxicity (> 2 nd degree) was minimal in these patients (p = 0.023) in comparison with the standard radiotherapy regimen.

Conclusions: Hypofractionated radiation therapy gives better results than traditional radiotherapy, due to lower fractional doses of radiation on the skin. The implemented method of hypofractionated radiation therapy in the program of complex treatment in patients with breast cancer made it possible to reduce the incidence of early radiation damage to the skin and subcutaneous fat. However, some toxic phenomena may take time to develop

Yеvgeniya O. Kossymbayeva 1, http//orcid.org/0000-0003-2893-0384

Tasbolat A. Adylkhanov 1, http//orcid.org/0000-0002-9092-5060

Daniyar T. Raissov 1, http://orcid.org/0000-0002-3872-1263

 

1 Clinical and radiation oncology department, Semey State Medical University,

Semey, Republic of Kazakhstan

1. Abiltayeva A. et al. Clinical , Histopathological and Molecular Characteristics of Metastatic Breast Cancer in North-Eastern Kazakhstan : a 10 Year Retrospective Study // Asian Pacific J. Cancer Prev. J Cancer Prev. 2016. V. 17. № 10. p. 4797–4802.

2. Agrawal R.K. et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial // Lancet. 2008.

3. Baissalbayeva A., Abiltayeva A. Hypofractionated radiotherapy in post-operative irradiation for breast cancer patients, 2014. 70 p

4. Beysebayev E. et al. Spatial and Temporal Epidemiological Assessment of Breast Cancer Incidence and Mortality in Kazakhstan, 1999-2013 // Asian Pac. J. Cancer Prev. 2015. Т. 16. № 15. p. 67-95.

5. Budach W., Blke E., Matuschek C. Hypofractionated radiotherapy as adjuvant treatment in early breast cancer. A review and meta-analysis of randomized controlled trials // Breast Care. 2015.

6. Ciammella P. et al. Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factors // Radiat. Oncol. 2014.

7. Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) // Int J Radiat Oncol Biol Phys. 1995. V. 31. № 5. p. 1341–1346.

8. Curado M.P., Voti L., Sortino-Rachou A.M. Cancer registration data and quality indicators in low and middle income countries: Their interpretation and potential use for the improvement of cancer care // Cancer Causes Control. 2009. Т. 20. № 5. p. 751–756.

9. Davis N.M. и др. Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention // Oncotarget. 2014. V. 5. № 13. p. 4603–4650.

10. Deantonio L. et al. Hypofractionated radiation therapy for breast cancer: Long-term results in a series of 85 patients // Tumori. 2016. V. 102. № 4. p. 398–403.

11. Dunnwald L.K., Rossing M.A., Li C.I. Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients // Breast Cancer Res. 2007.

12. Harper J.L. et al. Skin toxicity during breast irradiation: Pathophysiology and management // South. Med. J. 2004. V. 97. № 10. p. 989–993.

13. Hau E. et al. Radiotherapy breast boost with reduced whole-breast dose is associated with improved cosmesis: The results of a comprehensive assessment from the St. George and Wollongong randomized breast boost trial // Int. J. Radiat. Oncol. Biol. Phys. 2012.

14. Haviland J.S. et al. Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials // Radiother. Oncol. 2017. V. 12.

15. Jemal A. et al. Global cancer statistics // CA. Cancer J. Clin. 2011. V. 61. № 2. p. 69–90.

16. Kumar S. et al. Management of skin toxicity during radiation therapy: A review of the evidence // J. Med. Imaging Radiat. Oncol. 2010.

17. Lettmaier S. et al. Radiation exposure of the heart, lung and skin by radiation therapy for breast cancer: A dosimetric comparison between partial breast irradiation using multicatheter brachytherapy and whole breast teletherapy // Radiother. Oncol. 2011.

18. Lilla C. et al. Predictive factors for late normal tissue complications following radiotherapy for breast cancer // Breast Cancer Res. Treat. 2007. V. 106. № 1. p. 143–150.

19. Lin R., Tripuraneni P. Radiation Therapy in Early-Stage Invasive Breast Cancer // Indian J. Surg. Oncol. 2011.

20. McGale P. et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: Meta-analysis of individual patient data for 8135 women in 22 randomised trials // Lancet. 2014.

21. Meattini I. et al. Overview on cardiac, pulmonary and cutaneous toxicity in patients treated with adjuvant radiotherapy for breast cancer // Breast Cancer. 2017.

22. Naghavi M. The global burden of cancer 2013 // JAMA Oncol. 2015. V. 4. № 1. p. 52.

23. Newhauser W. International Commission on Radiation Units and Measurements Report 78: Prescribing, Recording and Reporting Proton-beam Therapy // Radiat. Prot. Dosimetry. 2009. V. 133. № 1. p. 60–62.

24. Smittenaar C.R. et al. Cancer incidence and mortality projections in the UK until 2035 // Br. J. Cancer. 2016. V. 115. p. 1147–1155.

25. Tortorelli G.et al. Standard or hypofractionated radiotherapy in the postoperative treatment of breast cancer: a retrospective analysis of acute skin toxicity and dose inhomogeneities.

: 1404


Косымбаева Е.О., Адылханов Т.А., Раисов Д.Т. Анализ показателей лучевых реакций кожи после проведения гипофракционированной лучевой терапии при раке молочной железы // Наука и Здравоохранение. 2018. 6 (Т.20). С. 114-120.

Kossymbayeva Yе.O., Adylkhanov T.A., Raissov D.T. Analysis of radiation reactions of skin after hypofractionated radiation therapy of breast cancer. Nauka i Zdravookhranenie [Science & Healthcare]. 2018, (Vol.20) 6, pp. 114-120.

Косымбаева Е.О., Адылханов Т.А., Раисов Д.Т. Сүт безі обыры кезіндегі гиперфракционды сәулелі терапиядан кейінгі терідегі сәулелі реакциялардың көрсеткіштерінің анализы // Ғылым және Денсаулық сақтау. 2018. 6 (Т.20). Б. 114-120.